Literature DB >> 3326833

Hodgkin's disease.

T S Vats.   

Abstract

Entities:  

Mesh:

Year:  1987        PMID: 3326833     DOI: 10.1007/bf02761009

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  19 in total

1.  Hodgkin's Disease, tonsillectomy and family size.

Authors:  N Gutensohn; F P Li; R E Johnson; P Cole
Journal:  N Engl J Med       Date:  1975-01-02       Impact factor: 91.245

2.  Thoracic CT scanning for mediastinal Hodgkin's disease: results and therapeutic implications.

Authors:  R A Rostock; S S Siegelman; R E Lenhard; M D Wharam; S E Order
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-10       Impact factor: 7.038

3.  Abnormal phytohemagglutinin-induced T-cell proliferative responses in Hodgkin's disease.

Authors:  R S Schulof; M J Lacher; S Gupta
Journal:  Blood       Date:  1981-03       Impact factor: 22.113

4.  An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.

Authors:  P M Mauch; H Weinstein; L Botnick; J Belli; J R Cassady
Journal:  Cancer       Date:  1983-03-01       Impact factor: 6.860

5.  An evaluation of space-time clustering in Hodgkin's disease.

Authors:  R S Greenberg; S Grufferman; P Cole
Journal:  J Chronic Dis       Date:  1983

6.  Complications of radiation treatment of Hodgkin's disease.

Authors:  T L Thar; R R Million
Journal:  Semin Oncol       Date:  1980-06       Impact factor: 4.929

7.  Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation.

Authors:  D Jenkin; H Chan; M Freedman; M Greenberg; M Gribbin; P McClure; F Saunders; M Sonley
Journal:  Cancer Treat Rep       Date:  1982-04

8.  Acute myeloid leukemia following treatment of Hodgkin's disease: a review.

Authors:  H W Grünwald; F Rosner
Journal:  Cancer       Date:  1982-08-15       Impact factor: 6.860

9.  Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.

Authors:  G Bonadonna; R Zucali; S Monfardini; M De Lena; C Uslenghi
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

10.  Second malignancies complicating Hodgkin's disease in remission.

Authors:  G P Canellos; J C Arseneau; V T DeVita; J Whang-Peng; R E Johnson
Journal:  Lancet       Date:  1975-04-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.